RESULTS	In patients who experienced recurrent bleeding , the celecoxib group showed a significantly higher median cost of management of recurrent bleeding than the diclofenac plus omeprazole group [ HK dollars 8466 ( range 572-29 ,851 ) vs. HK dollars 23,210 ( range HK dollars 12,318-65 ,823 ) ] ( P = 0.036 ) .\